Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI ...

In February 2026, Recursion Pharmaceuticals reported fourth-quarter 2025 revenue of US$35.54 million, sharply higher than a ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the most promising penny stocks under $5 to buy. On February 25, Recursion Pharmaceuticals reported its financial results for Q4 and the full ...

Recursion Pharmaceuticals, Inc ( (RXRX)) has held its Q4 earnings call. Read on for the main highlights of the call.

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the most promising penny stocks under $5 to buy. On February 25, Recursion Pharmaceuticals reported its financial results for Q4 and the full ...

Both Bank of America and JPMorgan are hosting conferences on the industrial sector, featuring presentations from companies including Boeing (BA) and American Airlines (AAL). Delta Air Lines (DAL) ...

Rose the dog might have just heralded the age of programmable medicine - and here are the stocks that benefit Pet owner Paul Conyngham (second right) and Professor Pall Thordarson discussed the cancer ...

As the program engages more directly with global concerns such as the climate crisis, he will lead the way.

After scaling his three-person startup Firebender to millions in revenue, Gottumukkala moves to Elon Musk’s artificial ...

Gottumukkala is best known as the co-founder of Firebender, an AI coding assistant designed for Android developers.